Figure 5From: Docking study of novel antihyperlipidemic thieno[2,3-d]pyrimidine; LM-1554, with some molecular targets related to hyperlipidemia - an investigation into its mechanism of action3D-docking of LM-1554 with the molecular target LDM. a. 3D-docking of LM-1554 into PDB structure of LDM. b. 3D-docking of native ligand, ketoconazole, into PDB structure of LDM.Back to article page